Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis.
Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients with ovarian cancer.
A standard diagnostic test for ovarian cancer is less effective in detecting the disease among Black and Native American ...
This was the case for Nefa-Tari Moore, 45, a three time "thriver" of gynecological cancer. The blood test for CA-125, a ...
The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American ...
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
Sonnet BioTherapeutics (SONN) announced safety results of SON-1010 at the highest dose combined with atezolizumab in the Phase 1b/2a clinical ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...